The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
S | Sensory organs | |
2
|
S01 | Ophthalmologicals | |
3
|
S01C | Antiinflammatory agents and antiinfectives in combination | |
4
|
S01CA | Corticosteroids and antiinfectives in combination |
| Code | Title | |
|---|---|---|
| S01CA01 | Dexamethasone and antiinfectives | |
| S01CA02 | Prednisolone and antiinfectives | |
| S01CA03 | Hydrocortisone and antiinfectives | |
| S01CA04 | Fluocortolone and antiinfectives | |
| S01CA05 | Betamethasone and antiinfectives | |
| S01CA06 | Fludrocortisone and antiinfectives | |
| S01CA07 | Fluorometholone and antiinfectives | |
| S01CA08 | Methylprednisolone and antiinfectives | |
| S01CA09 | Chloroprednisone and antiinfectives | |
| S01CA10 | Fluocinolone acetonide and antiinfectives | |
| S01CA11 | Clobetasone and antiinfectives | |
| S01CA12 |
| Document | Type | Information Source | |
|---|---|---|---|
| CIPRODEX Otic suspension | MPI, CA: SPM | Health Products and Food Branch (CA) | |
| MAXITROL Eye drops, suspension | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| TOBRADEX Eye drops, suspension | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| TOBRADEX Ophthalmic ointment | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| TOBRADEX Ophthalmic suspension | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| ZYLET Ophthalmic suspension | MPI, US: SPL/PLR | FDA, National Drug Code (US) |